A 2,813-bp HincH-ClaI DNA fragment encodes the two S and F components (LukS-R and LukF-R) of leucocidin R (Luk-R) 
Leucocidins are toxins secreted by Staphylococcus aureus. They consist of two separate and synergistic components. As emphasized by Gladstone and Van Heyningen (4), leucocidins' specific targets are monocytes, macrophages, and polymorphonuclear cells (PMNs), but these toxins do not induce significant hemolysis with the erythrocytes that are usually tested (27) . This characteristic allows us to distinguish between leucocidins and staphylococcal gamma hemolysin (6, 24) , since the latter, also acting by means of two separate components, is hemolytic and leukotoxic.
Up to now, two types of leucocidins have been reported. Panton et al. (13) identified a toxin, known as PantonValentine leucocidin (Luk-PV), in a supernatant of S. aureus V8 which was isolated from a patient suffering from chronic furunculosis. The biological activity of this toxin was studied by Woodin (28, 29) , who described the requirement of two exoproteins, F and S (32 and 38 kDa, respectively), which are separate but which nevertheless act synergistically upon human PMNs. The combination of these components (LukS-PV and LukF-PV) is not hemolytic with human erythrocytes. These results, except for the molecular masses of 38 and 32 kDa assigned to the F and S components, respectively, were recently confirmed by Finck-Barbancon et al. (2) . The difference in masses was probably due to the purification procedures used.
Noda et al. (11, 12) described extensively a seemingly different leukotoxin also produced by strain V8 and which also acts by means of two components, F and S (31 and 32 kDa, respectively), whose molecular masses were different from those first described by Woodin (29) . The activity of this second toxin on erythrocytes has never been clearly established. More recently, Rahman et al. (15, 16) reported the sequences of the S and F components of a leucocidin produced by a methicillin-resistant S. aureus (MRSA) strain whose biological properties were not documented. However, Finck-Barbancon et al. (2) reported that many S. * Corresponding author. aureus strains produced exoproteins showing partial identity to Luk-PV when immunoprecipitation was performed with affinity-purified Luk-PV antibodies. These results suggested that at least two kinds of leucocidin could be produced by S. aureus strains.
Another leucocidin (leucocidin R) produced by S. aureus P83 and isolated from an infected bovine udder was described by Soboll et al. (19, 20) and further studied by Loeffler et al. (9) . It has been shown that this toxin, which has never been highly purified, nevertheless has a specificity toward bovine and human PMNs, the latter being less sensitive. The activity of this toxin on erythrocytes has not been assessed. By using affinity-purified Luk-PV antibodies, we observed that a culture supernatant of S. aureus P83 contained products not identical but antigenically related to LukS-PV and LukF-PV, as described earlier (2) .
An oligonucleotide probe derived from the N-terminal sequence of LukF-PV from S. aureus ATCC 49775 (V8 strain) hybridized with the total DNA of strain P83. This probe allowed the purification of genes (lukS-R and lukF-R) encoding the so-called leucocidin R (Luk-R) on a 2,813-bp DNA fragment. We report here the sequence of these components and their expression in recombinant Escherichia coli. The two purified recombinant proteins showed immunoprecipitation lines identical to those obtained from a crude S. aureus P83 culture supernatant. They produced, when acting synergistically, leukotoxicity with PMNs from bovines and humans but also hemolysis with erythrocytes from various species. [A(lac-pro) supE thi hsdR (F' traD36 proAB lacIc ZM15)] was used as a host for the replication of the bacteriophages M13mpl8 and M13mpl9.
DNA screening and sequence determination. Restriction endonucleases and enzymes modifying DNA were used as recommended by the manufacturers (GIBCO-Bethesda Research Laboratories; Appligene, Strasbourg, France). For the cloning of lukF-R, ClaI DNA restriction fragments of total DNA from S. aureus P83 spanning from 1.5 to 2.5 kb were inserted into the AccI-linearized plasmid pUC19. For the cloning of lukS-R, HincII-AccI DNA restriction fragments of total DNA from the same strain ranging from 1.5 to 2.2 kb were inserted into the SmaI-AccI-linearized pUC19. E. coli NM522 was transformed (10) by the constructed plasmids, and the recombinant lukF-R and lukS-R clones were screened by a previously described dot blot method (17) with a 5'-labeled degenerated oligonucleotide probe. This oligonucleotide probe (5'-GTAATTT1lATC A/T AC C/T TT C/T TT C/T TC-3') was deduced from the underlined region of the N-terminal sequence of LukF-PV (AQHIT PVSEKKYDDKI) and was complementary to the mRNA. Hybridizations were performed overnight at 55°C in 6x SSPE (lx SSPE is 0.18 M NaCl, 10 (21) . For the analysis of mRNAs, total RNA was prepared from S. aureus P83 as described by Komblum et al. (7) , with modifications. Briefly, a volume of culture medium containing 7.5 x 108 bacteria (late-exponential-phase growth) was centrifuged at 4,000 x g for 10 min at 4°C, and the pellet was washed once in 5 ml of TES buffer (20 Nucleotide sequence accession number. Leucocidin R sequences were recorded in the EMBL data base under accession number X64389.
RESULTS
Cloning of lukS-R and lukF-R and expression of gene products. A 2.2-kb ClaI DNA fragment from total DNA of S.
aureus P83 was inserted intoAccI-cleaved pUC19 (Fig. 1B) (Fig. 3) . Therefore, the corresponding plasmid was called pUC-lukF-R. Upstream from the ORF corresponding to lukF-R, there was a truncated ORF whose amino acid translation showed a sequence (MDVTHAIKRST) homologous to that (MDVTHATRRDT) of a previously sequenced peptide (obtained after CNBr hydrolysis of the protein) of LukS-PV. This suggested that this new sequence was part of LukS-R, owing to the immunological relationship between LukS-PV and LukS-R. This observation led us to clone in E. coli a 1,537-bp HincII-AccI DNA fragment containing the whole gene of the S component and the 5' end of lukF-R (Fig. 1A) . The corresponding crude extract of recombinant E. coli contained a protein recognized by LukS-PV antibodies which was also able to produce a biological activity with human PMNs, but only when it was associated with LukF-PV or recombinant LukF-R. The corresponding plasmid was called pUC-lukS-R. A third plasmid, called pUCluk(S + F)-R, was constructed ( Fig. 1D) by the ligation of a 1,286-bp AccI-SphI DNA fragment from pUC-lukF-R to AccI-SphI-linearized pUC-lukS-R ( Fig. 1C and D ). E. coli transformed by pUC-luk(S + F)-R expressed proteins antigenically related to the S and F components of Luk-PV (Fig.  4 amino acids (62%) could be aligned (Fig. 6) with those mRNAs. A single mRNA was detected; it was about 2,000 to of the sequence of the expression product of bioX, a gene 2,100 bases long, as determined from the migration of E. coli of the biotin operon (22) , from Bacillus sphaenicus. More-16S and 23S rRNAs. The signal obtained was also located over, in this alignment, 58 amino acids (36%) were strictly between the positions of the S. aureus 16S and 23S rRNAs, identical to those of BioX, and 43 positions (26%) were whose respective lengths are not precisely known. This conservative substitutions of residues of the same amino mRNA size was in agreement with the lengths of both lukS-R acid family.
and lukF-R, including part of the promoter sequence of Transcription analysis. In order to determine whether lukS-R. This observation strongly suggested that lukS-R and LukS-R and LukF-R are translated from one or two lukF-R are tandemly transcribed in a single mRNA. At the mRNAs, a Northern blot analysis was performed with S. translation level, the luk-R mRNA is translated into two aureus P83 total RNA (Fig. 7) . The HincII-AccI DNA separate proteins, since the beginning of lukF-R is separated fragment from pUC-luk(S + F)-R was labeled by random from lukS-R by a stop codon. Using immunoblots on crude priming (10) and used as a probe for both lukS-R and lukF-R extracts from recombinant E. coli or S. aureus P83, we never 1111111111) 1111)111(1111) D) were analyzed by PFGE. Lanes: A, SmaI DNA fragments of the MRSA strain (described previously as PFGE fingerprint 1 [14] ) used as a DNA ladder; B, SmaI DNA fragments from S. aureus P83; C and D, hybridization of SmaI DNA fragments from the MRSA strain and from S. aureus P83 with the HincII-AccI probe (specific for lukS-R and lukF-R).
exoproteins. The mature protein, therefore, would contain 286 amino acids, for a calculated molecular mass of 32,689 Da and a calculated pI of 9.27. The LukS-R peptidic sequence does not reveal any cysteine residue and contains 4 tryptophan residues. There are 37 strongly basic residues (lysine and arginine) and 29 acidic residues (aspartic and glutamic acids). The basic and acidic amino acids are more widely distributed in the extremities of the protein. Among the 9 proline residues, 6 are encountered in a stretch of 26 residues (amino acids 214 to 239).
The second ORF encoded LukF-R, a 325-amino-acid protein. This protein was translated from the same mRNA as LukS-R, and a possible second RBS was found within the 3' end of lukS-R. The native protein was supposed to be cut after N-25 to give the secreted toxin, since the sequenced 10 respectively, from S. aureus P83 hybridized with a 1,522-bp random-labeled HincII-AccI DNA fragment specific for both lukS-R and lukF-R. The length of the detected mRNA (about 2,100 bases) was estimated by comparing the mobilities of the 1,540-base 16S and the 2,904-base 23S rRNAs from E. coli.
N-terminal extremity of the affinity-purified LukF-R was AEGKITPVSVKKVDD. The 25-amino-acid signal peptide so defined is constituted of 2 basic residues in the N-terminal part followed by 8 hydrophobic residues in the last 15 amino acids. This is also in agreement with commonly encountered signal peptide structures for exoproteins of S. aureus and other bacteria. The calculated molecular masses were 36,838 Da for the native and 34,203 Da for the mature LukF-R, with calculated pI of 9.3 and 9.2, respectively. The mature protein did not contain any cysteine residue and had 44 basic amino acids and 31 acidic residues. It also contained 127 polar and 98 hydrophobic amino acids. Five of the 6 tryptophan residues were distributed within the last 130 amino acids. The total charge was calculated to be 7.9 at pH 7.0. A lot of charged residues were encountered in the C-terminal extremity of LukF-R.
Comparison between purified Luk-PV and recombinant Luk-R components. As shown in Fig. 4 , the purified recombinant LukF-R (lane C) appeared as a single band in SDS-PAGE. Its apparent molecular mass was estimated to be 36 kDa, which was a bit lower than that estimated for LukF-PV (38 kDa) (Fig. 4, lane B) . This molecular mass value for LukF-R was between those calculated for the native and the mature proteins (36.8 and 34.2 kDa, respectively). On the basis of this sole SDS-PAGE observation, we have no evidence that LukF-R matured or was glycosylated in E. coli. This toxin component was recognized by affinitypurified LukF-PV antibodies in immunoblot experiments (data not shown) and seemed to have the same biological activities as the corresponding exoprotein secreted by S. aureus P83. For purified recombinant LukS-R (Fig. 4 , lane E), two proteins appeared by SDS-PAGE (Fig. 4) and were also evidenced by immunoblot experiments (data not shown). The protein with the lowest molecular mass (32 kDa) (Fig. 4, Associations of the latter are 1/1 molar ratios.
for LukS-R were in good accordance with those calculated for native and mature LukS-R from the lukS-R sequence.
Biological act'iv'ities. Toxidns in homologous and heterologous F + S combinations were tested with leukocytes and erythrocytes ( Table 1) . With human PMNs, Luk-PV was about 27 times more active (7 x 107 U/mg of each component) than Luk-R (2. Conversely, when tested with bovine PMNs, Luk-PV did not produce any significant leukotoxicity, whereas Luk-R had a simnilar activity with these bovine granulocytes and human granulocytes, monocytes, and macrophages. Moreover, the combination of heterologous components brought to light a more complex situation concerning the bovine granulocytes: the heterologous combination (LukF-R + LukS-PV) showed activity only four times less than that of Luk-R, whereas the biological activity of the heterologous (LukF-PV + LukS-R) association was 100 times less than that of Luk-R.
As for hemolysis, the experiments showed that Luk-PV and heterologous F + S combinations were not effective in lysing erythrocytes. Only Luk-R induced hemolysis of human, bovine, and rabbit erythrocytes.
DISCUSSION
We report here the sequence of so-called staphylococcal leucocidin R. The genes encoding the two components (LukS-R and LukF-R) of this toxin were cloned on a 2,813-bp DNA fragment. We demonstrated that a single mRNA, corresponding to the length of the two genes, was transcribed in S. aureus P83. In accordance with this observation, possible promoter consensus sequences were found only upstream from lukS-R, and an inverted-repeat sequence was found at the end of lukF-R, suggesting that the two ORFs could be cotranscribed by staphylococcal RNA polymerase. Therefore, the leucocidin R genes constitute an operon. The translation of lukF-R mRNA may occur by two procedures. In the first, after the release of the 50S ribosomal subunit induced by the stop codon of lukS-R, the 30S ribosomal subunit still remains attached to the mRNA and LukF-R translation could involve the release of the 30S ribosomal subunit from the mRNA. In this case, the RBS located upstream from lukF-R would be necessary for the initiation of translation, and only the first ATG of the lukF-R ORF should be used as the initiating codon because of its optimal distance to the RBS. For these reasons, the first ATG codon of the lukF-R ORF is likely to be the first codon to be translated because of its markedly more favorable situation. However, as observed with the first of the two steps of the cloning procedure, lukF-R alone could be expressed from pUC-lukF-R in E. coli, although the promoter of the luk-R operon was lacking. The major hypothesis which can explain this observation is that transcription of lukF-R in E. coli is mediated by the promoter of 3-galactosidase from the plasmid pUC19.
The hybridization of a specific probe of lukS-R and lukF-R (HincII-AccI DNA fragment) with P83 total DNA as a single band, even under low-stringency conditions, indicated that S. aureus P83 likely encodes only one leucocidin. This leucocidin appears to be chromosomally encoded for three reasons: (i) preparation of S. aureus plasmids by a CsCl gradient does not show any extrachromosomal genetic element, (ii) the two genes encoding leucocidin R are located in front of another ORF whose expression product has significant homologies with a chromosomally encoded protein constitutive of the biotin operon from B. sphaenicus (22) , and (iii) in PFGE experiments, hybridization with the specific probe of lukS-R and lukF-R evidenced a single, 300-kb chromosomal SmaI DNA fragment (Fig. 5B) in strain P83.
The cloned genes encoded the two components of leucocidin R, since their expression products induced the cell death of bovine and human PMNs, according to previous reports (20) . Moreover, the biological activities of these proteins were neutralized by Luk-PV antibodies. However, the cell specificities of Luk-R and Luk-PV were different. Luk-PV is toxic to human PMNs but not to bovine PMNs or erythrocytes. In contrast, the purified recombinant Luk-R had 27-fold less specific activity with human PMNs than that of Luk-PV but also induced lysis of bovine granulocytes. LukF-R seemed to be responsible for bovine leukocyte cell specificity when combined with LukS-PV, whereas for human granulocytes, LukF-PV or LukS-PV was able to increase the damage of glass-adsorbed granulocytes when combined with LukS-R or LukF-R, respectively. Furthermore, only Luk-R was responsible for hemolysis of bovine, human, or rabbit erythrocytes. The hemolytic activity of Luk-R was not due to contaminating hemolysins since recombinant Luk-R was used in these experiments and since crude extract of pUC19-transformed E. coli was not hemolytic. This hemolytic property had not yet been documented (9, 19, 20) , most likely because this toxin had never been purified to homogeneity. Therefore, so-called leucocidin R appeared to share many properties with the staphylococcal gamma-hemolysin. This was confirmed by peptidic sequence alignments (Fig. 3) of LukF-R to (i) the F component of the Rahman et al. (16) leucocidin, (ii) the known sequence (3) of the B component from gamma-hemolysin (HlgB), and (iii) the sequences of peptides from LukF-PV obtained after cyanogen bromide hydrolysis. All four of these sequences appeared to be closely related. Moreover, we also observed a randomly selected, methicillin-resistant staphylococcal strain which possessed a single set of genes hybridizing with the lukS-R-4ukF-R probe (Fig. 5B) . Cloning of luk-PV is now in progress in our laboratory, and data already available for LukF-PV and LukS-PV indicate that the sequence for Panton-Valentine leucocidin diverges the most from these sequences. Moreover, it was shown by SDS-PAGE (Fig. 4 ) that LukF-PV had a molecular weight higher than that of LukF-R, HlgB, or the F component of the Rahman et al. (16) leucocidin. LukF-R differed from HlgB by only 10 amino acids and from the F component of a leucocidin from an MRSA strain by 13 residues. Furthermore, the latter protein was different from HlgB by only 7 amino acids. Comparison of a peptidic sequence (Fig. 8) of LukS-R with that of the S component of another leucocidin (15) from an MRSA strain (15) evidenced only 7 differing amino acids. However, the hemolytic ability of the leucocidin (15) from the MRSA strain was not reported.
These observations clearly demonstrate that staphylococcal gamma-hemolysins and leucocidins constitute a single family of toxins acting by means of two separate protein components to damage the membranes of PMNs and macrophages or those of PMNs, macrophages, and erythrocytes. Therefore, the study of staphylococcal leucocidins (or gamma-toxins) is required in order to assess the structural polymorphism of this family of toxins, as well as the spectrum of sensitive cells for each of these toxins. The name for these toxins should also be modified to take into account the fact that they act on cell membranes by means of two separate and synergistic components. We propose to call them synergohymenotropic toxins, because they act by the cooperation of two components (synergy) and because they are directed (tropism) against cell membranes (hymen). As Luk-PV-producing strains are highly associated with furuncles and primitive cutaneous abcesses (1), the association of the other staphylococcal two-component toxins with particular pathological features should also be determined.
